Low-cost anti-mycobacterial drug discovery using engineered E. coli.
Bongaerts N, Edoo Z, Abukar AA, Song X, Sosa-Carrillo S, Haggenmueller S, Savigny J, Gontier S, Lindner AB, Wintermute EH
Nat Commun. 2022 Jul 7;13(1):3905. doi: 10.1038/s41467-022-31570-3. PubMed Article
Bongaerts N, Edoo Z, Abukar AA, Song X, Sosa-Carrillo S, Haggenmueller S, Savigny J, Gontier S, Lindner AB, Wintermute EH
Nat Commun. 2022 Jul 7;13(1):3905. doi: 10.1038/s41467-022-31570-3. PubMed Article
Plasmids from Article
| ID | Plasmid | Purpose |
|---|---|---|
| 169110 | pNB101 | Feedback-controlled AraC circuit |
| 169111 | pNB200 | TESEC backbone for target expression |
| 169112 | pNB201 | TESEC expression vector for Alr from M. tuberculosis |
| 169113 | pNB202 | TESEC expression vector for mEGFP |
| 169114 | pNB203 | TESEC expression vector for mEGFP-Alr fusion construct |
| 169115 | pNB204 | TESEC expression vector for 6xHis-Alr fusion constrcut |
| 169116 | pNB205 | TESEC expression vector for Asd from M. tuberculosis |
| 169117 | pNB206 | TESEC expression vector for CysH from M. tuberculosis |
| 169118 | pNB207 | TESEC expression vector for DapB from M. tuberculosis |
| 169119 | pNB208 | TESEC expression vector for TrpD from M. tuberculosis |